Today we are discussing Delta Plus Group, a leading European player in Personal Protective Equipment (PPE).
đ„ Delta Plus in a Nutshell
The Business: A âOne-Stop-Shopâ for workplace safety. They sell everything from helmets to boots, covering the worker from âHead-to-Toe.â
Highly recurren Revenue , driven by the mandatory regulatory nature of PPE, mitigating cyclical risk from its end-markets (Construction, Industry).
The Moat: Regulatory barriers. Certifications are slow, expensive, and tedious.
The Strategy: Consolidating a fragmented market via M&A and pivoting toward the "Upmarket" (high-margin technical products).
The Opportunity: A post-COVID "hangover" has compressed the valuation, creating an entry point that doesn't reflect the long-term fundamentals.
Alignment: Controlled by the founding family. Real Skin in the Game.
1. Business Overview: Protection by Decree
Delta Plus Group is a global designer, manufacturer, and distributor of Personal Protective Equipment (PPE). The company distinguishes itself through a comprehensive "One-Stop-Shop" approach, covering the full "Head-to-Toe" spectrum of workplace safety: Head, Hand, Body, Foot, and Fall Protection.Their value proposition to their network of 10,000+ distributors is simplicity. Instead of managing 10 different suppliers, a distributor calls Delta and equips an entire workforce.
They operate a hybrid model, manufacturing 63% of their products internally (specifically in high-margin segments like Safety Footwear and Fall Protection) and outsourcing the rest. Geographically, they are well-hedged: 50% Europe, 50% International (Americas and Asia).
Why is this business resilient? This is the beauty of the model. They sell to cyclical end-markets (construction, oil & gas, heavy industry), yet their revenue stream is not that cyclical.
If a recession hits, a factory might delay CapEx on a new assembly line, but it cannot legally operate without gloves, boots, and harnesses. There is a hard âregulatory floorâ under their demand. Layoffs would affect the business, but there would never be a significant drop in revenue.
The Proof: During the height of the pandemic lockdowns, while Delta benefited from mask sales, non-COVID products declined by only 3.1%.
Growth Strategy
Geographic Expansion: Aggressive growth in emerging economies where safety regulations are tightening from a low base.
The âUpmarketâ Shift: This is key for margins. They are deliberately increasing the mix of high-value technical products (specifically Fall Protection) over commodity items.
M&A Consolidator: The market is fragmented, . Since 2019, they have closed over 10 acquisitions. As of FY 2024, the pipeline is full: 382 targets identified, with 129 qualified and 37 garnering strong interest.
2.Industry & Competitive Landscape
The global PPE market is a $70â$80 billion giant with structural growth projected between 4.5% and 7.3% for the next 5 years.
The Product Mix
Consumables (Gloves, Masks): High frequency, recurring. Demand only drops if the production line stops.
Light Equipment (Helmets, Boots): Moderate lifecycle. Demand is floored by expiration dates and wear-and-tear. The cost of a fine for non-compliance far outweighs the cost of a new pair of boots.
Barriers to Entry
You can't just start selling safety gear tomorrow. Certification processes take 12-18 months and require significant R&D spend. This creates a moat. Scale allows Delta to dilute these regulatory costs, whereas small players struggle.
The Consolidation Thesis
There are different types of companies in the industry.
Giants (3M): PPE is a small division. They have premium brands, but not the agility.
Specialists (Ansell, Uvex): Deep expertise and global presence in one niche.
Local Players: Thousands of small, family-owned firms. These are Deltaâs M&A targets.
Multi-specialist aggregators (Delta):This group consists of companies that have grown beyond a niche market, yet still lack the size of conglomerates. . Their strategy is to grow by acquiring smaller companies to build a complete range of offerings (âone-stop shopâ). Their success depends on logistical efficiency and post-acquisition integration.
Delta is the ideal consolidator. Buying a âŹ100m revenue company is nothing(+3% growth) for a giant like 3M. For Delta, that same deal drives ~25% growth. This "size leverage" allows Delta to compound faster than the mega-caps.
Current Context: The Post-COVID Hangover We are currently normalizing after the 2020-2022 distortion.
Volume contraction in pandemic categories.
Destocking by distributors.
Price pressure from overcapacity.
Impact: Sales dipped 5% in 2024. This temporary weakness is exactly why the opportunity exists today.
3. Management & OwnershipSkin in the Game
The company has been controlled by the Benoit family since 1977. JérÎme Benoit (son of the founder) has been CEO since 2011. The family holds ~57% of the capital.
Capital Allocation Their priority is M&A, but they are disciplined. They are actively pivoting Upmarket, buying companies with better margins than the group average. While M&A has integration risk, the Benoit familyâs track record here is solid.
4. Risks & Catalysts
Risk
The âMiddleâ Problem: Delta lacks the premium pricing power of 3M and the niche depth of a specialist. They compete on value-for-money. They must scale to survive.
Private Label: Large distributors are pushing their own brands, exerting deflationary pressure on low-end goods.
Recession: While mandatory, a severe global recession would slow organic growth.
Catalysts
âSweet Spotâ Scale: Delta is big enough to access capital markets for deals, but small enough that bolt-on acquisitions still move the needle materially.
End of Normalization: The inventory correction is ending. As we lap the difficult post-COVID comps, earnings acceleration should return.
Margin Expansion: The shift to high-margin technical gear (Upmarket) is structurally improving EBIT margins.
5. Financial Analysis
(See the PDF packet for full statements)
Revenue Growth its moderate but stable . Total CAGR is 8.2% since 2012. Purely organically (stripping out FX and M&A), growth is 4.3%. For a defensive business, that is acceptable.
Profitability We are seeing a clear upward trend in margins, driven by economies of scale and the Upmarket pivot. While recent years were noisy, the long-term trajectory is positive.
Return on Invested Capital (ROIC) Since Delta grows via both organic means and M&A, we look at ROIC two ways:
Total ROIC (avg 12 years): 14%. This includes the goodwill from acquisitions.
ROIC ex-Goodwill: 25.6%. This confirms this a good business.
Leverage
Net Debt (ex-leases) is 2.5x LTM EBITDA. This is moderate for business with such recurrent revenue.
Cash conversion
Cash conversion is volatile due to working capital.The average adjusted conversion is 93.1%, while the unadjusted average remains high at 88.1%.Over the past 10 years, the average has been 70%.
6. Valuation
We use three methods to triangulate the value.
1. Comparable Company Analysis
We excluded 3M due to conglomerate distortion. Additionally, we excluded Lakelandâs non-normalized results for 2025. Even compared to a relevant peer group, Delta trades at a discount ranging from 28% to 57%.
My take: European small-caps often trade cheaper than US peers like MSA Safety, but this gap is too wide to be explained by geography alone.
2. Historical Valuation
The stock is trading below its own historical averages. If we look at 2026 estimates (when margins normalize), the discount is around 20%.
3. Discounted Cash Flow (DCF)
Modeling M&A is a guessing game, so we modeled only organic growth to see if the current price offers a safety margin.
Inputs: Conservative 4.5% growth (low end of industy estimates), 14.8% EBITDA margin (return to 2019 levels), and a 13.2x Exit Multiple.
Result: At âŹ47.50, the Implied IRR is 9.7%.
Conclusion on Valuation
We are getting a near 10% annual return based only on conservative organic growth.
7.Final Verdict
Delta Plus is a defensive company. Its sales are protected by law. It is currently priced as if the post-COVID inventory correction is permanent, rather than temporary.
Setting aside the valuation models, here is the simple math:
I expect total growth (Organic + M&A) to hover near 8% annually.
Add the dividend yield of 2.4%.
Factor in likely margin expansion from the Upmarket shift.
We are looking at an annual return of roughly 10% driven solely by fundamentals, without needing a market re-rating. If the market does re-rate the stock back to historical norms, the upside is significantly higher.
The risk-return relationship is excellent.
Disclaimer: This write-up is for informational purposes only and does not constitute investment advice.
Thanks for reading.
If you enjoyed this analysis on Delta Plus, make sure you are subscribed so you donât miss the next one.








